1. Home
  2. SEB vs ADPT Comparison

SEB vs ADPT Comparison

Compare SEB & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaboard Corporation

SEB

Seaboard Corporation

N/A

Current Price

$3,744.59

Market Cap

3.8B

Sector

Industrials

ML Signal

N/A

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$29.19

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEB
ADPT
Founded
1918
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.5B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
SEB
ADPT
Price
$3,744.59
$29.19
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $32.57
AVG Volume (30 Days)
10.7K
★ 2.0M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 0.24%
N/A
EPS Growth
★ 467.71
63.89
EPS
★ 313.22
N/A
Revenue
★ $5,809,000,000.00
$276,976,000.00
Revenue This Year
N/A
$10.85
Revenue Next Year
N/A
$21.60
P/E Ratio
$11.86
★ N/A
Revenue Growth
7.99
★ 54.77
52 Week Low
$3,309.11
$12.00
52 Week High
$5,989.37
$32.21

Technical Indicators

Market Signals
Indicator
SEB
ADPT
Relative Strength Index (RSI) 46.32 58.55
Support Level $3,309.11 $24.02
Resistance Level $3,937.17 $29.92
Average True Range (ATR) 152.76 1.83
MACD 16.71 0.35
Stochastic Oscillator 69.01 60.05

Price Performance

Historical Comparison
SEB
ADPT

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: